FdaApplication
NDA 216142
Identifiers
- fda_app_no: NDA216142
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2023-09-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION;INTRAVENOUS |
| MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION;INTRAVENOUS |
| MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION;INTRAVENOUS |
3 products